A candidate for cancer gene therapy: MIP-1α gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice

Emi Nakashima, Akiko Oya, Yuri Kubota, Naomi Kanada, Ryo Matsushita, Kazuyoshi Takeda, Fujio Ichimura, Kouji Kuno, Naofumi Mukaida, Kunitaka Hirose, Isao Nakanishi, Toshimitsu Ujiie, Kouji Matsushima

研究成果: Article

65 引用 (Scopus)

抜粋

Purpose. The evaluate the possibility of cancer gene therapy by the gene delivery of chemokine, the effects of human macrophage inflammatory protein 1α (hu-MIP-1α), murine-macrophage inflammatory protein 1α (mu-MIP-1α), and human-interleukin 8 (hu-IL-8) on tumor progression and immunization were studied. Methods. Cachexia-inducing and highly tumorigenic adenocarcinoma cells (cell line colon 26, clone 20) were transfected with either a control plasmid, hu-MIP-1α, mu-MIP-1α, or hu-IL-8 expression vector. The production of hu-MIP-1α reached > 1.5 ng/ml in vitro when transfectant cells were cultured at a cell density of 2 x 10 5 cells in 7 ml for 3 days. Immunocompetent BALB/c mice were inoculated into the footpad with the tumor cells, and then primary tumor growth, morphological analyses, and tumor immunogenicity were studied. Results. The secretion of hu-MIP-1α, mu-MIP-1α, and hu-IL-8 did not affect the growth rate in vitro. Reduced tumorigenicities in vivo were observed in transfected cells with hu-MTP-1α and mu-MIP-1α. Morphologic observation of the site of inoculation of cells transfected with hu-MIP-1α showed infiltration of macrophages and neutrophils on the 5th day after the inoculation. Mice that had rejected cells transfected with hu-MIP-1α gene were immune to a subsequent challenge with the parental cells. Conclusions. The rejection of the cells depends on cytolysis and generates potent and long lasting antitumor immunity. These data suggest that tumor cells transfected with the MIP-1α gene might be useful as an effective therapy for the treatment of certain tumors.

元の言語English
ページ(範囲)1896-1901
ページ数6
ジャーナルPharmaceutical research
13
発行部数12
DOI
出版物ステータスPublished - 1996 12 1

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

フィンガープリント A candidate for cancer gene therapy: MIP-1α gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Nakashima, E., Oya, A., Kubota, Y., Kanada, N., Matsushita, R., Takeda, K., Ichimura, F., Kuno, K., Mukaida, N., Hirose, K., Nakanishi, I., Ujiie, T., & Matsushima, K. (1996). A candidate for cancer gene therapy: MIP-1α gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice. Pharmaceutical research, 13(12), 1896-1901. https://doi.org/10.1023/A:1016057830271